Both Omega-3, Placebo Help With Aromatase Inhibitor-Induced Pain

This article originally appeared here.
Share this content:
Both Omega-3, Placebo Help With Aromatase Inhibitor-Induced Pain
Both Omega-3, Placebo Help With Aromatase Inhibitor-Induced Pain

THURSDAY, May 7, 2015 (HealthDay News) -- For patients with early-stage breast cancer treated with aromatase inhibitors (AIs), arthralgia is improved with omega-3 fatty acid (O3-FA) treatment and with placebo, according to a study published online May 4 in the Journal of Clinical Oncology.

Dawn L. Hershman, M.D., from the Columbia University Medical Center in New York City, and colleagues randomized 249 women with early-stage breast cancer receiving an AI who had a worst joint pain/stiffness score of ≥5 of 10 using the Brief Pain Inventory-Short Form (BPI-SF) to receive O3-FAs (122 patients) or placebo (127 patients) for 24 weeks. Patients completed quality-of-life and additional pain and stiffness assessments at baseline and at weeks six, 12, and 24.

The researchers found that the mean observed BPI-SF score decreased by 1.74 and 2.22 points at 12 and 24 weeks, respectively, with O3-FAs, and by 1.49 and 1.81 points, respectively, with placebo, compared with baseline. Twelve-week BPI-SF scores did not differ by arm (P = 0.58) after adjustment for baseline score, osteoarthritis, and taxane use. In patients receiving O3-FA treatment, triglyceride levels decreased, while they remained stable for patients receiving placebo (P = 0.01).

"We found no evidence that O3-FAs improved joint pain or stiffness associated with AIs any more than placebo; however, we did find a large reduction in symptoms in both the treatment and placebo groups," the authors write.

Several authors disclosed financial ties to the pharmaceutical and biopharmaceutical industries.

Abstract
Full Text (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »